All In MedTech

FDA Clearance Tracker · P980022-S089

PARADIGM REAL-TIME REVEL INSULIN PUMP

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 13, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 13, 2010

Approved

Time to decision

9 days

Received Oct 4, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P980022-S089
Device name
PARADIGM REAL-TIME REVEL INSULIN PUMP
Applicant location
Northridge, CA
Received
Oct 4, 2010
Decided
Oct 13, 2010
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P980022

Device type

Device class
Class III

Every decision under product code MDS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE TRADE NAME CHANGE FOR PARADIGM REAL-TIME REVEL INSULIN PUMP (MODELS MMT-523, MMT-723, MMT-523K, MMT-723K). THE NEW TRADE NAME FOR THESE INSULIN PUMPS IS PARADIGM REAL-TIME REVEL INSULIN PUMP.

Source documents

Other decisions for Medtronic Minimed

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.